Inhaled Fluticasone and Salmeterol Suppress Eosinophilic Airway Inflammation in Chronic Obstructive Pulmonary Disease: Relations with Lung Function and Bronchodilator Reversibility

Author： Perng Diahn-Warng   Wu Cheng-Che   Su Kang-Cheng   Lee Yu-Chin   Perng Reury-Perng   Tao Chi-Wei  

Publisher： Springer Publishing Company

ISSN： 0341-2040

Source： Lung, Vol.184, Iss.4, 2006-08, pp. : 217-222

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhaled Salmeterol/Fluticasone Propionate Combination in Chronic Obstructive Pulmonary Disease

By Lyseng-Williamson K.A.   Keating G.M.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 4, 2002-04 ,pp. : 273-282

Adis International

Access to resources Recommend Favorite

Inhaled Salmeterol/Fluticasone Propionate Combination in Chronic Obstructive Pulmonary Disease: A Viewpoint by Wilfried De Backer

By de Backer W.  

American Journal of Respiratory Medicine, Vol. 1, Iss. 4, 2002-04 ,pp. : 283-284

Adis International

Access to resources Recommend Favorite

Inhaled Corticosteroids and Pneumonia in Chronic Obstructive Pulmonary Disease

By  

Current Respiratory Medicine Reviews, Vol. 6, Iss. 3, 2010-08 ,pp. : 162-166

Bentham Science Publishers

Access to resources Recommend Favorite

Use of Forced Inspiratory Vital Capacity to Identify Bronchodilator Reversibility in Obstructive Lung Disease

By Biring Manmohan   Madison Susan   Mohsenifar Zab  

Journal of Asthma, Vol. 38, Iss. 6, 2001-09 ,pp. : 495-500

Informa Healthcare

Access to resources Recommend Favorite

Is Airway Inflammation in Chronic Obstructive Pulmonary Disease (COPD) a Risk Factor for Cardiovascular Events?

By Calverley Peter   Scott Stephen  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 3, Iss. 4, 2006-12 ,pp. : 233-242

Informa Healthcare

Access to resources Recommend Favorite